MediApp India is revolutionizing the pharmaceutical industry in India with its largest B2B digital network of Distributors and Retailers for Generic Medicines. The company's mobile application, MediApp, aggregates Quality Generics covering 95% of the entire generic drug requirement, aiming to make Quality Generics affordable and accessible to millions through retail chemists. With a current user base of 15,460 chemists and a presence in 203 districts PAN India, MediApp is working towards building the largest E-Commerce Pharma Distribution Channel Platform connecting chemists. The company prioritizes Quality (Grade ‘A’ Products with Pharmacopoeia +5%), Transparency, and Convenience for both retailers and MediApp Prime Stockists.
Founded in 2017 and headquartered in India, MediApp has positioned itself as a one-stop platform for generics from leading brands and certified factories. The company's innovative approach and extensive reach in the Indian pharmaceutical market make it a promising venture for potential investors.